Legal status in the United States

Is Pramlintide legal?

Read at FDA, DEA and WADAPublished by PepVault

Pramlintide was FDA-approved as Symlin in 2005, and Drugs@FDA now lists it as discontinued, is not a federally controlled substance, and is not named on WADA’s Prohibited List, as of November 18, 2026.

Pramlintide at a glance

CheckStatus, read Nov 18, 2026
FDA approvalApproved 2005; discontinued (Drugs@FDA)
CompoundingComponent of an approved drug (503A condition)
DEA scheduleNot controlled
Sport (WADA)Not named on the list

FDA approval

Pramlintide was FDA-approved as Symlin in 2005. Drugs@FDA, read November 18, 2026, lists all three Symlin products as discontinued, and the SymlinPen label on DailyMed gives the pens a marketing end date of January 31, 2027.

  • Symlin (injection (pen))

    Approved for an add-on for people with type 1 or type 2 diabetes who use mealtime insulin and haven’t reached their blood sugar goal. NDA 021332, first approved March 16, 2005; discontinued.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Compounding

Pramlintide is the active ingredient of an FDA-approved drug (Symlin), which Drugs@FDA lists as discontinued. FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name pramlintide.

The source: “Are components of FDA-approved drug products if an applicable USP or NF monograph does not exist”

DEA schedule

It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

Sport (WADA)

The 2026 Prohibited List doesn’t name pramlintide, and S0, the class for unapproved substances, doesn’t reach an approved drug.

What this means and doesn’t

This page reports what the agencies’ own pages said about Pramlintide in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

Questions

  • Is Pramlintide FDA approved?

    Pramlintide was FDA-approved as Symlin in 2005. Drugs@FDA, read November 18, 2026, lists all three Symlin products as discontinued, and the SymlinPen label on DailyMed gives the pens a marketing end date of January 31, 2027.

  • Is Pramlintide a controlled substance?

    It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

  • Is Pramlintide banned in sport?

    The 2026 Prohibited List doesn’t name pramlintide, and S0, the class for unapproved substances, doesn’t reach an approved drug.

  • What does FDA say about compounding Pramlintide?

    Pramlintide is the active ingredient of an FDA-approved drug (Symlin), which Drugs@FDA lists as discontinued. FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name pramlintide.

Read next

Track it in the app

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo